Compassionate Use Programs or Phase IV Trials of Innovative Molecular Targeted Drugs in Lung Cancer: Deal or No Deal?
Journal of Thoracic Oncology - United States
doi 10.1097/jto.0b013e3181f41b1c
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2010
Authors
Publisher
Elsevier BV